PubMed

Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial.

Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM, Schaumberg DA.

Diabetes Care. 2008 Dec;31(12):2338-43. Epub 2008 Sep 16.PMID: 18796620 [PubMed - indexed for MEDLINE]Related articlesFree article

Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.

Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.

Diabetes Care. 2008 Jun;31(6):1170-6. Epub 2008 Mar 10.PMID: 18332153 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.

Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM.

Circulation. 2005 May 17;111(19):2446-53. Epub 2005 May 2.PMID: 15867184 [PubMed - indexed for MEDLINE]Related articlesFree article

Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.

Nelson CL, Karschimkus CS, Dragicevic G, Packham DK, Wilson AM, O'Neal D, Becker GJ, Best JD, Jenkins AJ.

Nephrol Dial Transplant. 2005 Nov;20(11):2420-6. Epub 2005 Aug 22.PMID: 16115854 [PubMed - indexed for MEDLINE]Related articlesFree article

Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.

Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk CG, Tarnow L, Parving HH.

Scand J Clin Lab Invest. 2008;68(8):731-8.PMID: 18609080 [PubMed - indexed for MEDLINE]Related articles

YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.

Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H.

Diabetes Care. 2009 Feb;32(2):323-8. Epub 2008 Oct 28.PMID: 18957531 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.

Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, Jaffa M, Jenkins AJ, Lyons TJ, Garvey WT, Virella G; Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort Study Group.

Diabetes Care. 2008 Oct;31(10):2006-12. Epub 2008 Jul 15.PMID: 18628568 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.

Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH.

Diabetes. 2002 Apr;51(4):1157-65.PMID: 11916939 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy.

Clausen P, Jacobsen P, Rossing K, Jensen JS, Parving HH, Feldt-Rasmussen B.

Diabet Med. 2000 Sep;17(9):644-9.PMID: 11051283 [PubMed - indexed for MEDLINE]Related articles

Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, Warram JH, Krolewski AS.

Clin J Am Soc Nephrol. 2009 Jan;4(1):62-70. Epub 2008 Dec 10.PMID: 19073786 [PubMed - indexed for MEDLINE]Related articles

Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.

Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G.

Diabet Med. 2005 Aug;22(8):999-1004.PMID: 16026364 [PubMed - indexed for MEDLINE]Related articles

Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.

Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A.

Diabetes Care. 1999 Nov;22(11):1865-70.PMID: 10546021 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.

De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.

J Intern Med. 2005 Jan;257(1):100-9.PMID: 15606381 [PubMed - indexed for MEDLINE]Related articles

C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.

Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.

Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):593-8.PMID: 11950696 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.

Schalkwijk CG, Poland DC, van Dijk W, Kok A, Emeis JJ, Dräger AM, Doni A, van Hinsbergh VW, Stehouwer CD.

Diabetologia. 1999 Mar;42(3):351-7.PMID: 10096789 [PubMed - indexed for MEDLINE]Related articles

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.

Meigs JB, Hu FB, Rifai N, Manson JE.

JAMA. 2004 Apr 28;291(16):1978-86.PMID: 15113816 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.

Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study.

Diabetes Care. 2003 Jul;26(7):2165-73.PMID: 12832330 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.

Seddon JM, George S, Rosner B, Rifai N.

Arch Ophthalmol. 2005 Jun;123(6):774-82.PMID: 15955978 [PubMed - indexed for MEDLINE]Related articles

Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study.

Hoogeveen RC, Ballantyne CM, Bang H, Heiss G, Duncan BB, Folsom AR, Pankow JS.

Diabetologia. 2007 Jan;50(1):36-42. Epub 2006 Nov 29.PMID: 17136392 [PubMed - indexed for MEDLINE]Related articles

Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

[No authors listed]

Diabetes. 1997 Nov;46(11):1829-39.PMID: 9356033 [PubMed - indexed for MEDLINE]Related articles